TrialESMO open2025
Phase I study of H3B-6545 in patients with estrogen receptor-positive breast cancer.
K Yonemori et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialESMO open2025
K Yonemori et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.